Hankø E, Lindemann R, Hansen T W
Department of Paediatrics, Ullevål Hospital, University of Oslo, Norway.
Acta Paediatr. 2001 Jul;90(7):782-5.
The increasing number of case reports on neurologic sequelae related to hyperbilirubinaemia may represent a re-emergence of kernicterus in the industrialized world. However, not much has been written about infants who survived extreme levels of serum bilirubin without neurologic damage. We present three cases of extreme neonatal hyperbilirubinaemia, all with peak serum bilirubin levels >600 micromol/L. Two of the infants developed neurologic sequelae, but the third infant did not. In contrast to the two with sequelae, the infant without sequelae was female, had a positive Coombs' test, less clinical signs compatible with bilirubin encephalopathy, and a shorter exposure to serum bilirubin values >400 micromol/L.
The basic mechanism of bilirubin neurotoxicity remains unknown, and it is not clear why some infants do not develop neurologic injury at serum bilirubin levels at which others do. We speculate that a comparison between patients with sequelae and those without may yield important information.
与高胆红素血症相关的神经系统后遗症病例报告数量不断增加,这可能意味着工业化国家中核黄疸的再度出现。然而,关于血清胆红素水平极高却未出现神经损伤而存活下来的婴儿,相关报道较少。我们报告三例新生儿重度高胆红素血症病例,所有病例血清胆红素峰值均>600微摩尔/升。其中两名婴儿出现神经系统后遗症,而第三名婴儿未出现。与两名有后遗症的婴儿相比,未出现后遗症的婴儿为女性,库姆斯试验呈阳性,与胆红素脑病相符的临床体征较少,且血清胆红素值>400微摩尔/升的暴露时间较短。
胆红素神经毒性的基本机制尚不清楚,也不清楚为何有些婴儿在其他婴儿出现神经损伤的血清胆红素水平时却未出现神经损伤。我们推测,对比有后遗症和无后遗症的患者可能会得出重要信息。